Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 046242/0346 | |
| Pages: | 14 |
| | Recorded: | 06/29/2018 | | |
| Attorney Dkt #: | P-330-US1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/03/2019
|
Application #:
|
15966467
|
Filing Dt:
|
04/30/2018
|
|
Publication #:
|
|
Pub Dt:
|
11/01/2018
| | | | |
|
Title:
|
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND
|
|
|
Assignee
|
|
|
|
|
| 901 GATEWAY BLVD |
| SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
|
Correspondence name and address
|
| |
THERAVANCE BIOPHARMA US, INC.
|
| |
901 GATEWAY BLVD
|
| |
SOUTH SAN FRANCISCO, CA 94080
|
Search Results as of:
05/08/2024 10:30 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
